100 likes | 244 Views
Vasilatos et al . Relative LSD1 mRNA (%) (HDAC siRNA vs. Scramble) . MDA-MB-231 cells. Figure S1. Vasilatos et al . NR4A1. mRNA level (Fold) Relative to MDA-MB-231 . PCDH1. mRNA level (Fold) Relative to MDA-MB-231 . RGS16. mRNA level (Fold) Relative to MDA-MB-231 . BIK.
E N D
Vasilatos et al. Relative LSD1 mRNA (%) (HDAC siRNA vs. Scramble) MDA-MB-231 cells Figure S1
Vasilatos et al. NR4A1 mRNA level (Fold) Relative to MDA-MB-231 PCDH1 mRNA level (Fold) Relative to MDA-MB-231 RGS16 mRNA level (Fold) Relative to MDA-MB-231 BIK mRNA level (Fold) Relative to MDA-MB-231 Figure S2
Vasilatos et al. A LSD1 LSD1 P=0.189 B HDAC5 HDAC5 P=0.677 Figure S3
SAHA- + A CDKN1A b-Actin Cytoplasmic Nuclear CDKN1A PCNA MDA-MB-231 B SAHA Pargyline - - + + - + - + NR4A1 b-actin Cytoplasmic Nuclear NR4A1 PCNA MDA-MB-468 Figure S4
Vasilatos et al. Supplemental Table 1. Thirty-six breast cancer cell lines used in this study. ER-estrogen receptor; PR-progesterone receptor; Lu-luminal; BaA-Basal A; BaB-Basal B; HER2-human epidermal growth receptor 2; HR-hormone receptor positive; TN-triple negative.
Vasilatos et al. Table S2.Gene expression induced by treatment with SAHA in MDA-MB-231 cells
Vasilatos et al. Table S3.Gene expression reduced by treatment with SAHA in MDA-MB-231 cells.